Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk

Mohsen Saravani1,2, Hossein Shahraki-Ghadimi1,3, Rostam Maruei-Milan2

  • 1Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.

Insights

The TT genotype and T allele of the mammalian target of rapamycin (mTOR) rs2295080 polymorphism significantly increase systemic lupus erythematosus (SLE) risk. Other tested mTOR and AKT1 gene variations showed no association with SLE development.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Rheumatology

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune disease with significant systemic inflammatory consequences.
  • The mammalian target of rapamycin (mTOR) pathway is recognized as a potential therapeutic target for autoimmune disorders, including SLE.
  • Genetic variations in key molecular pathways may influence individual susceptibility to SLE.

Purpose of the Study:

  • To investigate the association between specific polymorphisms in the mTOR (rs2295080, rs2536) and AKT1 (rs2494732) genes and the risk of developing SLE.
  • To identify potential genetic risk factors that could contribute to SLE pathogenesis.

Main Methods:

  • Peripheral blood samples were collected from 165 SLE patients and 170 healthy controls.
  • DNA was extracted using the salting-out method.
  • Genotyping and analysis of mTOR rs2295080 and rs2536, and AKT1 rs2494732 polymorphisms were performed using the PCR-RFLP technique.

Main Results:

  • The TT genotype of the mTOR rs2295080 polymorphism was found at a significantly higher frequency in SLE patients compared to controls.
  • Individuals with the TT genotype of mTOR rs2295080 exhibited a 2.6-fold increased risk of developing SLE.
  • A significant difference in allelic distribution for mTOR rs2295080 was observed between the patient and control groups.
  • No statistically significant association was detected between the mTOR rs2536 and AKT1 rs2494732 polymorphisms and SLE development.

Conclusions:

  • The TT genotype and the T allele of the mTOR rs2295080 polymorphism are identified as significant risk factors for developing SLE.
  • The studied polymorphisms in mTOR rs2536 and AKT1 rs2494732 do not appear to be associated with SLE risk in the studied population.
  • These findings highlight the role of specific mTOR genetic variations in SLE susceptibility, suggesting potential avenues for further research.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K